Sugammadex: An Update

1. Shields M, Giovannelli M, Mirakhur K, et al. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolongedrocuronium-induced neuromuscular block. Br J Anaesth. 2006;96:36-43.10.1093/bja/aei31416357116Search in Google Scholar

2. Fortier LP, McKeen D, Turner K, de Medicis E, et al. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade. AnesthAnalg. 2015;121:366-72.10.1213/ANE.000000000000075725902322Search in Google Scholar

3. Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth. 2015;115:743-51.10.1093/bja/aev10425935840Search in Google Scholar

4. Ledowski T, Ong JS, FlettT. Neuromuscular Monitoring, Muscle Relaxant Use, and Reversal at a Tertiary Teaching Hospital 2.5 Years after Introduction of Sugammadex: Changes in Opinions and Clinical Practice. Anesthesiol Res Pract. 2015;2015:367937.Search in Google Scholar

5. Partownavid P, Romito BT, Ching W, Berry AA, Barkulis CT, Nguyen KP, JahrJS. Sugammadex: A Comprehensive Review of the Published Human Science, Including Renal Studies. Am J Ther.2015;22:298-317.10.1097/MJT.000000000000010325299638Search in Google Scholar

6. Benigni A, Maffioletti M, Spotti A, Benigni AM, Locatelli BG, Sonzogni V. Efficacy and safety of a sugammadex dose of 4 mg/ kg in early reversal of a deep neuromuscular block rocuroniuminduced in infants and children: a case series. Eur J Anaesthesiol. 2013;30:161-2.10.1097/00003643-201306001-00504Search in Google Scholar

7. Plaud B, Meretoja O, Hofmockel R, et al. Reversal of rocuroniuminduced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009;110:284-94.10.1097/ALN.0b013e318194caaa19194156Search in Google Scholar

8. Meretoja OA. Neuromuscular block and current treatment strategies for its reversal in children. Paediatr Anaesth. 2010;20:591-604.10.1111/j.1460-9592.2010.03335.x20642658Search in Google Scholar

9. Staikou C, Stamelos M, Stavroulakis E. Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity. Br J Anaesth. 2014;112:217-30. 10 Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review.Anaesthesia. 2014;69:1251-7.10.1111/anae.1273624848211Search in Google Scholar

11. McDonnell NJ, Pavy TJ, Green LK, Platt PR. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth. 2011;106:199-201.10.1093/bja/aeq36621149287Search in Google Scholar

12. Plaud B. A new option for the treatment of anaphylaxis linked to steroidal neuromuscular blockers: How much value should we grant to case reports? Can J Anaesth. 2014;61:511-8.Search in Google Scholar

13. Cammu G, Van Vlem B, van den Heuvel M, et al. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment. Br J Anaesth. 2012;109:382-90.10.1093/bja/aes20722732111Search in Google Scholar

14. Rahe-Meyer N, Fennema H, Schulman S, et al. Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients. Anesthesiology.2014;121:969-77.10.1097/ALN.000000000000042425208233Search in Google Scholar

15. WATAG (Western Australian Therapeutic Advisory Group): Sugammadex Guidelines - July 2013 (online source) - http://www.watag.org.au/watag/docs/SUGAMMADEX_Guidelines%20and%20Audit%20July13.pdf.Search in Google Scholar

16. Veelo DP, Gisbertz SS, Hannivoort RA, et al. The effect of ondemand vs deep neuromuscular relaxation on rating of surgical and anaesthesiologic conditions in patients undergoing thoracolaparoscopicesophagectomy (DEPTH trial): study protocol for a randomized controlled trial. Trials. 2015;16:331.10.1186/s13063-015-0849-0452616626242177Search in Google Scholar

17. Evron S, Yakobashvili S, Rigini N, Ezri T. Successful Reversal with Sugammadex of Deep Neuromuscular Block Caused by Rocuronium and Magnesium Sulfate in a Patient with H.E.L.P Syndrome. Acta Medica Marisiensis. 2012;58:7.Search in Google Scholar

18. Pühringer FK, Kristen P, Rex C. Sugammadex reversal of rocuronium-induced neuromuscular block in caesarean section patients: a series of seven cases. Br J Anaesth. 2010;105:657-60.10.1093/bja/aeq22720736231Search in Google Scholar

19. Williamson RM, Mallaiah S, Barclay P. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia. Acta Anaesthesiol Scand. 2011;55:694-9.10.1111/j.1399-6576.2011.02431.x21480829Search in Google Scholar

20. Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuroniuminduced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth. 2012;108:236-9.10.1093/bja/aer33022012861Search in Google Scholar

21. Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients.Anaesthesia. 2011;66:721-5.10.1111/j.1365-2044.2011.06782.x21692760Search in Google Scholar

22. Suzuki T, Masaki G, Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br J Anaesth. 2006;97:160-3.10.1093/bja/ael14216782976Search in Google Scholar

23. Illman HL, Laurila P, Antila H, Meretoja OA, Alahuhta S, Olkkola KT. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring. Anesth Analg. 2011;112:63-8.10.1213/ANE.0b013e3181fdf88920978247Search in Google Scholar

24. Ezri T, Evron S, Petrov I, Schachter P, Berlovitz P, Shimonov M. Residual curarization and postoperative respiratory complications following laparoscopic sleeve gastrectomy. The effect of reversal agents: sugammadex vs. neostigmine. J Crit Care Med. 2015;1:61-67.10.1515/jccm-2015-0009595328929967817Search in Google Scholar

25. El-Orbany M, Connolly LA. Rapid sequence induction and intubation: current controversy. Anesth Analg. 2010;110:1318-25.10.1213/ANE.0b013e3181d5ae4720237045Search in Google Scholar

26. Taha SK, El-Khatib MF, Baraka AS, et al. Effect of suxamethonium vs rocuronium on onset of oxygen desaturation during apnoea following rapid sequence induction. Anaesthesia. 2010;65:358-61.10.1111/j.1365-2044.2010.06243.x20402874Search in Google Scholar

27. Donati F. Neuromuscular blocking agents. In Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega R: Clinical anesthesia, 7th ed., chapter 20, page 533, Wolters Kluwer, Philadelphia 2013.Search in Google Scholar

28. Sorensen M.K, Bretlau C, Gatke MR, Sorensen AM, Rasmussen LS. Rapid sequence induction and intubation with rocuroniumsugammadex compared with succinylcholine: A randomized trial. Br J Anaesth. 2012;108:682-9.10.1093/bja/aer50322315329Search in Google Scholar

29. Mendonca C. Sugammadex to rescue a ‘can’t ventilate’ scenario in an anticipated difficult intubation: is it the answer? Anaesthesia. 2013;68:795-9.Search in Google Scholar

30. Bisschops MMA, Holleman C, Huitink JM. Can sugammadex save a patient in a simulated ‘cannot intubate, cannot ventilate’ situation? Anaesthesia. 2010;65:936-41.Search in Google Scholar

31. Curtis R, Lomax S, Patel B. Use of sugammadex in a ‘can’t intubate, can’t ventilate’ situation. Br J Anaesth. 2012;108:612-4.10.1093/bja/aer49422287458Search in Google Scholar

32. Kyle BC, Gaylard D, Riley RH. A persistent ‘can’t intubate, can’t oxygenate’ crisis despite rocuronium reversal with sugammadex. Anaesth Intensive Care. 2012;40:344-6.10.1177/0310057X120400022022417032Search in Google Scholar

33. Karalapillai D, Kaufman M, Weinberg L. Sugammadex. Crit Care Resusc. 2013;15:57-62.Search in Google Scholar

34. Ortega-Gonzalez M. Anaesthesia for trauma patients. S Afr Fam Pract. 2012;54(Suppl 1):S2-S6. 10.1080/20786204.2012.10874227Search in Google Scholar